Search

Search Constraints

Start Over Filtering by: Keyword multiple myeloma Remove constraint Keyword: multiple myeloma

Search Results

  • Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
  • Trans-differentiation of plasma cell neoplasm to acute myeloid leukemia with monocytic features: Case report of divergent phenotype with identical genotype
  • Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401
  • Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial
  • Loss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma
  • GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells
  • Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study
  • Keeping Myeloma in Check: The Past, Present and Future of Immunotherapy in Multiple Myeloma
  • Overall survival with oral selinexor plus low-dose dexamethasone versus real-world therapy in triple-class-refractory multiple myeloma.
  • Gene expression profiling impacts treatment decision making in newly diagnosed multiple myeloma patients in the prospective PROMMIS trial